LONDON, U.K. -- SMi Group invites you to attend the 2nd annual Quality by Design conference (http://www.smi-online.co.uk/goto/2014qbd-conference.asp?emref=P-092EL410000023&) , taking place on the 24th and 25th of February 2014 in London. Attend this conference and learn how to successfully implement Quality by Design to create a formulation process, with an introduction to QbD and PAT by Mr Peter Boogaard, Founder, Industrial Lab Automation.
This presentation is an introduction to the key components of QbD which are crucial for any individual look into to implement QbD in their business. Adoption of an integrated Product Quality Lifecycle Process facilitates innovation, continual improvement and strengthens the link between pharmaceutical development and manufacturing activities.
• Introduction to QbD concept and update on ICH Q10 and QbD Pharmaceutical Quality Systems guideline
• Overview of PAT technologies and industry examples in both development and manufacturing
• Introductory overview of Product Quality Lifecycle Implementation (PQLI) and Introduction to the 4 Product Quality System elements (PQS)
This conference will bring together both academia and industry experts to provide you in-depth knowledge about several topics such as:
Advanced Systems in Quality by Design Processes
QbD in biotherapeutics and formulation development
Continuous process development and QbD
Analytical method development
Key presentations include:
QbD at the interface of development to production
Andreas Schreiner, Head Validation Manufacturing Science & Technology, Novartis
Early screening of manufacturing to improve biotherapeutic design and selection
Paul Dalby, Co-director of the EPSRC Centre for Innovative Manufacturing in Emergent Macromolecular Therapies, University College London
Approaches in selecting and designing a safer biopharmaceutical
Norma Scully, Small Molecule R&D, Eli Lilly & Company
Plant-wide control for integrated continuous pharmaceutical manufacturing
Richard Lakerveld, Assistant Professor, Delft University Of Technology
The potential for imaging in the pharmaceutical industry
Michel Ulmschneider, Scientific Specialist, Project Manager Spectroscopy and Chemometrics, F Hoffman - La Roche A G
Shifting tides in pharmaceutical manufacturing — Making continuous processing a reality
Marcel de Matas, Principal Scientist Formulation Science, AstraZeneca
Development of data management and analysis platform for continuous secondary processes
Simeone Zomer, Technical Manager, GlaxoSmithKline
Application of novel PAT and QbD principles to enhancing material and process understanding
Mingzhong Li, Principal Lecturer, De Montfort University
For more information on the programme and speakers please visit www.smi-online.co.uk/2014qbd-conference6.asp
Contact
Husaina Durrant
+44 (0) 20 7827 6070
hdurrant@smi-online.co.uk
